| Dr Richard Michael Berger, MD | |
|
70 Doctors Park, Cape Girardeau, MO 63703-4928 | |
| (573) 334-6071 | |
| (573) 334-4739 |
| Full Name | Dr Richard Michael Berger |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 37 Years |
| Location | 70 Doctors Park, Cape Girardeau, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780683003 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 0428073 (Kansas) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 2016025637 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Owensboro Health Regional Hospital | Owensboro, KY | Hospital |
| Union Hospital Inc | Terre haute, IN | Hospital |
| Southwest General Health Center | Middleburg heights, OH | Hospital |
| Blessing Hospital | Quincy, IL | Hospital |
| Hurley Medical Center | Flint, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Imaging Associates Of Indiana Pc | 1254503345 | 202 |
| Specialists In Medical Imaging Sc | 2163733544 | 201 |
| Louisville Radiology Imaging Consultants Pllc | 2264436120 | 54 |
| Northside Radiology Associates Llc | 4486555398 | 213 |
| Columbus Radiology Corp | 6507754983 | 271 |
| Murfreesboro Radiology And Nuclear Medicine Consultants Pllc | 7719964063 | 62 |
| Adi Radiology Pc | 7911236427 | 67 |
| Coastal Radiology Associates Pllc | 8224002696 | 88 |
| Greensboro Radiology Pa | 8729074901 | 207 |
| Imaging Associates Of Michigan Pllc | 9537434386 | 66 |
| Hurley Medical Center | 2961308481 | 264 |
| Murfreesboro Radiology And Nuclear Medicine Consultants Pllc | 7719964063 | 62 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Louisville Radiology Imaging Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639115447 PECOS PAC ID: 2264436120 Enrollment ID: O20130517000055 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Imaging Associates Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699072611 PECOS PAC ID: 1254503345 Enrollment ID: O20150106000375 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Specialists In Medical Imaging Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841687951 PECOS PAC ID: 2163733544 Enrollment ID: O20150626000251 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Murfreesboro Radiology & Nuclear Medicine Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316043524 PECOS PAC ID: 7719964063 Enrollment ID: O20160127000166 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Blessing Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1114471737 PECOS PAC ID: 3072422534 Enrollment ID: O20161005001836 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Columbus Radiology Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669408159 PECOS PAC ID: 6507754983 Enrollment ID: O20170417000208 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Coastal Radiology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144270307 PECOS PAC ID: 8224002696 Enrollment ID: O20171006001707 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Imaging Associates Of Michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164943007 PECOS PAC ID: 9537434386 Enrollment ID: O20180124000265 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Greensboro Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821035999 PECOS PAC ID: 8729074901 Enrollment ID: O20200715002483 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Northside Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013960657 PECOS PAC ID: 4486555398 Enrollment ID: O20200903003699 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Entity Name | Adi Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083266761 PECOS PAC ID: 7911236427 Enrollment ID: O20230919001820 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Michael Berger, MD 70 Doctors Park, Cape Girardeau, MO 63703-4928 Ph: (573) 334-6071 | Dr Richard Michael Berger, MD 70 Doctors Park, Cape Girardeau, MO 63703-4928 Ph: (573) 334-6071 |
News Archive
Rhythm announced today the initiation of an additional Phase 2 clinical trial for RM-131, the company's novel ghrelin agonist, for the treatment of chronic constipation. Ghrelin is a peptide hormone produced in the stomach that stimulates gastrointestinal motility.
A Nevada jury has awarded three plaintiffs $500 million in punitive damages after finding negligence.
Novartis is highlighting data from an ongoing Phase II clinical study of CTL019, an investigational chimeric antigen receptor (CAR) T cell therapy, that indicate its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma.
Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.
› Verified 1 days ago
Karen B Willens, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 70 Doctors Park, Cape Girardeau, MO 63703 Phone: 573-335-6671 | |
Jeffrey William Boss, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 70 Doctors Park, Cape Girardeau, MO 63703 Phone: 573-334-6071 Fax: 573-334-4739 | |
Dr. Lance C. Faler, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 70 Doctors Park, Cape Girardeau, MO 63703 Phone: 573-334-6071 | |
Dr. Justin Ray Hodge, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 70 Doctor's Park, Cape Girardeau, MO 63703 Phone: 573-334-6071 Fax: 573-334-4739 | |
Abel Assefa Belay, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 70 Doctors Park, Cape Girardeau, MO 63703 Phone: 573-334-6071 | |
Yuan Yuan Xie, Radiology Medicare: Accepting Medicare Assignments Practice Location: 70 Doctors Park, Cape Girardeau, MO 63703 Phone: 573-334-6071 Fax: 573-334-4739 | |
Dr. George A. Pjura, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 70 Doctors Park, Cape Girardeau, MO 63703 Phone: 573-334-6071 Fax: 573-334-4739 |